A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells

Elena Gugiatti, Claudya Tenca, Silvia Ravera, Marina Fabbi, Fabio Ghiotto, Andrea N. Mazzarello, Davide Bagnara, Daniele Reverberi, Daniela Zarcone, Giovanna Cutrona, Adalberto Ibatici, Ermanno Ciccone, Zbigniew Darzynkiewicz, Franco Fais, Silvia Bruno

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e531-e536
JournalHaematologica
Volume103
Issue number11
DOIs
Publication statusPublished - Nov 1 2018

ASJC Scopus subject areas

  • Hematology

Cite this

Gugiatti, E., Tenca, C., Ravera, S., Fabbi, M., Ghiotto, F., Mazzarello, A. N., Bagnara, D., Reverberi, D., Zarcone, D., Cutrona, G., Ibatici, A., Ciccone, E., Darzynkiewicz, Z., Fais, F., & Bruno, S. (2018). A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells. Haematologica, 103(11), e531-e536. https://doi.org/10.3324/haematol.2017.175414